ArticleCancers2026

Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab.

Maeva Ullmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.